Profile data is unavailable for this security.
About the company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
- Revenue in USD (TTM)81.58bn
- Net income in USD15.30bn
- LocationJohnson & Johnson1 Johnson And Johnson PlzNEW BRUNSWICK 08933-0001United StatesUSA
- Phone+1 (732) 524-2455
- Fax+1 (732) 214-0332
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|JNJ:NYQ since |
|Innovalens BV||Deal completed||15 Feb 2019||15 Feb 2019Deal completed||2.13%||--|
|Ci:z Holdings Co Ltd||Announced||23 Oct 2018||23 Oct 2018Announced||-1.09%||1.33bn|
|CIC Corp||Announced||23 Oct 2018||23 Oct 2018Announced||-1.09%||711.33m|
|EIT Emerging Implant Technologies GmbH||Announced||31 Aug 2018||31 Aug 2018Announced||1.65%||--|
|Actelion Pharmaceuticals Korea Ltd||Deal completed||23 Mar 2018||23 Mar 2018Deal completed||7.69%||5.49m|